Evaluation of Risk Factors for Coinfection or Cocolonization with Vancomycin-resistant Enterococcus and Methicillin-resistant Staphylococcus Aureus
Overview
Authors
Affiliations
We retrospectively evaluated 410 patients with coinfection or cocolonization due to vancomycin-resistant (VR) enterococcus (VRE) and methicillin-resistant Staphylococcus aureus (MRSA). The prevalence rate was 19.8%. Risk factors included isolation of VR Enterococcus faecalis and use of linezolid or clindamycin. Inc18-like vanA plasmids were found in 7% of VR E. faecalis isolates and none of the VR E. faecium isolates.
suppresses -induced NETosis and promotes bacterial survival in polymicrobial infections.
Kao P, Chng J, Chong K, Stocks C, Wong S, Kline K FEMS Microbes. 2023; 4:xtad019.
PMID: 37900578 PMC: 10608956. DOI: 10.1093/femsmc/xtad019.
An Enzybiotic Cocktail Effectively Disrupts Preformed Dual Biofilm of and .
Manoharadas S, Ahmad N, Altaf M, Alrefaei A, Al-Rayes B Pharmaceuticals (Basel). 2023; 16(4).
PMID: 37111322 PMC: 10145859. DOI: 10.3390/ph16040564.
Vancomycin resistant infections: A review of case updating and clinical features.
Cong Y, Yang S, Rao X J Adv Res. 2020; 21:169-176.
PMID: 32071785 PMC: 7015472. DOI: 10.1016/j.jare.2019.10.005.
She P, Zhou L, Li S, Liu Y, Xu L, Chen L Front Microbiol. 2019; 10:2453.
PMID: 31708908 PMC: 6821689. DOI: 10.3389/fmicb.2019.02453.
Yoon Y, Lee M, Ju Y, Lee S, Yang K, Sohn J Ann Clin Microbiol Antimicrob. 2019; 18(1):28.
PMID: 31601221 PMC: 6785887. DOI: 10.1186/s12941-019-0327-8.